Refsum's Disease—Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder

Refsum's Disease is an inherited metabolic disorder in which a metabolite of branched chain fatty acids accumulates due to lack of appropriate oxidative enzymes. Patients have elevated plasma phytanic acid levels and high concentrations of phytanic acid in a variety of tissues leading to progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Nimalie J., Lewis, Barry, Tran, Huy, Fietz, Michael, Sullivan, David R.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943115/
https://www.ncbi.nlm.nih.gov/pubmed/20871815
http://dx.doi.org/10.1155/2011/482021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943115/
https://www.ncbi.nlm.nih.gov/pubmed/20871815
http://dx.doi.org/10.1155/2011/482021

Ejemplares similares